Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Safety and feasibility of robot-assisted radical prostatectomy for clinically localized prostate cancer in elderly Japanese patients.

Nishikawa M, Watanabe H, Kurahashi T.

Prostate Int. 2017 Mar;5(1):13-16. doi: 10.1016/j.prnil.2017.01.001. Epub 2017 Jan 12.

2.

Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study.

Björklund J, Folkvaljon Y, Cole A, Carlsson S, Robinson D, Loeb S, Stattin P, Akre O.

BJU Int. 2016 Aug;118(2):302-6. doi: 10.1111/bju.13404. Epub 2016 Feb 15.

3.

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

Schmid M, Meyer CP, Reznor G, Choueiri TK, Hanske J, Sammon JD, Abdollah F, Chun FK, Kibel AS, Tucker-Seeley RD, Kantoff PW, Lipsitz SR, Menon M, Nguyen PL, Trinh QD.

JAMA Oncol. 2016 Jan;2(1):85-93. doi: 10.1001/jamaoncol.2015.3384.

4.

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.

Suidan RS, Leitao MM Jr, Zivanovic O, Gardner GJ, Long Roche KC, Sonoda Y, Levine DA, Jewell EL, Brown CL, Abu-Rustum NR, Charlson ME, Chi DS.

Gynecol Oncol. 2015 Aug;138(2):246-51. doi: 10.1016/j.ygyno.2015.05.034. Epub 2015 May 31.

5.

Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis.

Islam KM, Wen J.

Prostate Cancer. 2015;2015:829439. doi: 10.1155/2015/829439. Epub 2015 Apr 20.

6.

Recommendations on screening for prostate cancer with the prostate-specific antigen test.

Canadian Task Force on Preventive Health Care, Bell N, Connor Gorber S, Shane A, Joffres M, Singh H, Dickinson J, Shaw E, Dunfield L, Tonelli M.

CMAJ. 2014 Nov 4;186(16):1225-34. doi: 10.1503/cmaj.140703. Epub 2014 Oct 27. No abstract available.

7.

Standardized follow-up program may reduce emergency room and urgent care visits for patients undergoing radical prostatectomy.

Flannigan RK, Gotto GT, Donnelly B, Carlson KV.

Can Urol Assoc J. 2014 Jul;8(7-8):E505-9. doi: 10.5489/cuaj.1655.

8.

Optimal management of colorectal liver metastases in older patients: a decision analysis.

Yang S, Alibhai SM, Kennedy ED, El-Sedfy A, Dixon M, Coburn N, Kiss A, Law CH.

HPB (Oxford). 2014 Nov;16(11):1031-42. doi: 10.1111/hpb.12292. Epub 2014 Jun 24. Review.

9.

Does gender influence morbidity or mortality in the surgical treatment of renal masses?

Minnillo BJ, Horowitz A, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R.

Can Urol Assoc J. 2014 May;8(5-6):E311-6. doi: 10.5489/cuaj.1674.

10.

Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy.

Hansen J, Gandaglia G, Bianchi M, Sun M, Rink M, Tian Z, Meskawi M, Trinh QD, Shariat SF, Perrotte P, Chun FK, Graefen M, Karakiewicz PI.

Can Urol Assoc J. 2014 Jan-Feb;8(1-2):E75-80. doi: 10.5489/cuaj.749.

11.

Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Xiao H, Tan F, Goovaerts P, Ali A, Adunlin G, Gwede CK, Huang Y.

Am J Mens Health. 2014 Jul;8(4):316-26. doi: 10.1177/1557988313512862. Epub 2013 Dec 1.

12.

Comorbidity and survival of Danish prostate cancer patients from 2000-2011: a population-based cohort study.

Nguyen-Nielsen M, Nørgaard M, Jacobsen JB, Borre M, Thomsen RW, Søgaard M.

Clin Epidemiol. 2013 Nov 1;5(Suppl 1):47-55. doi: 10.2147/CLEP.S47153. eCollection 2013.

13.

Variation in quality of care among older men with localized prostate cancer.

Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB.

Cancer. 2011 Jun 1;117(11):2520-9. doi: 10.1002/cncr.25812. Epub 2010 Dec 14.

14.
15.

Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.

Jembere N, Campitelli MA, Sherman M, Feld JJ, Lou W, Peacock S, Yoshida E, Krahn MD, Earle C, Thein HH.

PLoS One. 2012;7(7):e40917. doi: 10.1371/journal.pone.0040917. Epub 2012 Jul 13.

16.

Impact of age at diagnosis on prostate cancer treatment and survival.

Bechis SK, Carroll PR, Cooperberg MR.

J Clin Oncol. 2011 Jan 10;29(2):235-41. doi: 10.1200/JCO.2010.30.2075. Epub 2010 Dec 6.

17.

Comorbidity and mortality results from a randomized prostate cancer screening trial.

Crawford ED, Grubb R 3rd, Black A, Andriole GL Jr, Chen MH, Izmirlian G, Berg CD, D'Amico AV.

J Clin Oncol. 2011 Feb 1;29(4):355-61. doi: 10.1200/JCO.2010.30.5979. Epub 2010 Nov 1.

18.

Novel diagnostic biomarkers for prostate cancer.

Madu CO, Lu Y.

J Cancer. 2010 Oct 6;1:150-77.

19.

Perioperative fatal embolic cerebrovascular accident after radical prostatectomy.

Ghaly RF, Candido KD, Knezevic NN.

Surg Neurol Int. 2010 Jul 1;1. pii: 26. doi: 10.4103/2152-7806.65055.

20.

Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression.

Singh RK, Sudhakar A, Lokeshwar BL.

J Cancer Sci Ther. 2010;2(4):89-94.

Supplemental Content

Support Center